Dr. Brian W. Cooper, MD

Dr. Cooper practices at HCA Florida Orange Park Hospital in Orange Park, Florida, part of HCA Healthcare.

Dr. Cooper's NPI, 1023032307, was assigned on July 27, 2006. Dr. Cooper graduated from Tufts University School Of Medicine in 1979. Dr. Cooper holds Florida license ME114000.

Dr. Cooper's primary practice is HCA Florida Orange Park Hospital, at 2001 Kingsley Ave, Orange Park, FL 32073 in Clay County. The practice phone is (904) 276-8500.

Dr. Cooper's primary practice is HCA Florida Orange Park Hospital in Orange Park, Florida, part of HCA Healthcare. Dr. Cooper is also affiliated with Brooks Rehabilitation Hospital - University Campus. The medical group on file is First Coast Infectious Disease Consultants.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cooper practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Cooper's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Cooper is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Cooper's licenses on file in 2 states: Florida and Connecticut.

CMS data shows 1,726 Medicare services from Dr. Cooper across 3 procedure codes in 2024, for 600 Medicare patients. Medicare paid $125,655 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 600 Medicare patients who saw Dr. Cooper in 2024. The largest group is 75 to 84, with 236 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 3.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cooper's median patient age at 62, with 45% women.

In 2024, Dr. Cooper wrote 172 Medicare Part D claims for 47 patients. 80% of them were for generic drugs. CMS names the drug for 129 of them, across 5 drugs with 11 or more claims each, at $46,098 in total drug cost. In 2023, CMS named 167 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Cooper for performance year 2024, reported individually.

Dmand AI links 25 papers to Dr. Cooper, published from 2011 to 2013. 2011 was the busiest year, with 2. The most frequent topics are Anti-Bacterial Agents, Cross Infection and Vaccination. Dr. Cooper has published most often in Infect Control Hosp Epidemiol. Dr. Cooper's most frequent co-authors are Robert E. Levitz, MD and Jeffrey Jackson Stoddard, MD.

CMS Open Payments shows 273 general payments to Dr. Cooper from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Merck Sharp & Dohme Corporation paid the most, $1,396.

Dmand AI lists 1 award for Dr. Cooper.

Dr. Cooper graduated from Tufts University School Of Medicine in 1979. Dr. Cooper is a member of ACP and IDSA.

Dr. Cooper is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.